Dimethyl Acetamide Prices In China

China: 1148 USD/MT

The price of dimethyl acetamide (DMAc) in China for Q4 2023 reached 1148 USD/MT in December.

The latest report by IMARC Group, titled "Dimethyl Acetamide Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data," provides a thorough examination of the Prices. This report delves into the price of Dimethyl Acetamide globally, presenting a detailed analysis, along with informative Dimethyl Acetamide Price Chart. Through comprehensive Price analysis, the report sheds light on the key factors influencing these trend. Additionally, it includes historical data to offer context and depth to the current pricing landscape. The report also explores the Demand, analyzing how it impacts Industry dynamics. To aid in strategic planning, the price forecast section provides insights into price forecast, making this report an invaluable resource for industry stakeholders.

Report Offering:

Monthly Updates: Annual Subscription
Quarterly Updates: Annual Subscription
Biannually Updates: Annual Subscription

The study delves into the factors affecting dimethyl acetamide price variations, including alterations in the cost of raw materials, the balance of supply and demand, geopolitical influences, and sector-specific developments.

The report also incorporates the most recent updates from the market, equipping stakeholders with the latest information on market fluctuations, regulatory modifications, and technological progress. It serves as an exhaustive resource for stakeholders, enhancing strategic planning and forecast capabilities.

Request For a Sample Copy of the Report: https://www.imarcgroup.com/dimethyl-acetamide-pricing-report/requestsample

Dimethyl Acetamide Price Trend Last Quarter

The extensive demand in the pharmaceutical industry for efficient and reliable solvents represents one of the key factors driving the market growth of dimethyl acetamide (DMAc) worldwide. Moreover, the use of DMAc in the production of pharmaceuticals and agrochemicals is becoming increasingly popular which is a major growth-inducing factor. In addition to this, the textile industry is expanding at a rapid pace which includes the use of DMAc-based products, thereby significantly contributing to the market growth. Besides this, consumers are more interested in high-quality and safe materials which, in turn, is propelling the market growth.

Apart from this, significant technological progress in DMAc production and processing is bolstering the market growth. Additionally, the increased usage of DMAc in premium fabric compositions and high-end items is stimulating market growth. Furthermore, personalization and customization are becoming increasingly popular in material engineering. The expanding uses for DMAc in household and industrial applications are boosting the market growth of DMAc globally.

The increasing popularity of renewable energy and energy-efficient products is one of the pivotal factors driving the market growth of DMAc worldwide. Moreover, the key industrial companies are increasing their investments in research and developmental (R&D) activities which, in turn, is propelling the market growth. Expanding online shopping and marketing to increase product accessibility is acting as a major growth-inducing factor.

Dimethyl Acetamide Industry Analysis

The global dimethyl acetamide market size reached US$ 111.4 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 136.5 Million, at a projected CAGR of 2.30% during 2023-2032. In the last quarter of 2023, Dimethylacetamide (DMAc) prices experienced a notable uptrend across several key markets, including North America, Asia-Pacific (APAC), and Europe.

This increase was predominantly driven by heightened demand from downstream industries such as textiles, polymers, and pharmaceuticals, which placed considerable pressure on existing supplies. In North America, the bullish trend was further influenced by the dynamics of upstream markets, particularly the prices of dimethylamine, which supported the upward movement of DMAc prices, despite acetic acid showing an opposite trend.

The scarcity of product supplies, coupled with robust demand, empowered market players to adjust their ex-quotations upwards to enhance profit margins. Buyers, in response to the tightening market, leaned towards bulk procurement strategies in an effort to stabilize the supply-demand equilibrium. Additionally, producers in the region were prompted to ramp up their production rates in an attempt to smooth out the supply chain and meet the increased consumption rate, necessitating a restocking of storage facilities to cope with the surging demand from key sectors.

In the APAC region, particularly in China, the market for DMAc exhibited similar bullish trend, characterized by an approximate 8% price increase towards the quarter's end, with the latest price standing at USD 1152/MT FOB-Nanjing. This was largely attributed to a pronounced supply-demand imbalance, exacerbated by manufacturers reducing their production capacity and a potential rise in energy prices, threatening to further escalate production costs.

Despite no reported plant shutdowns, the persistent low supply against a backdrop of strong market sentiment and increased demand from sectors such as textiles, pharmaceuticals, and coatings compelled traders to marginally raise their prices. Europe mirrored these trend, where DMAc prices also saw an upward trajectory, influenced by limited supplies and increased demand from the textile and polymer manufacturing sectors.

Across all regions, the dynamics between upstream components, the strategic adjustments of market players, and the overarching supply-demand imbalances were critical in shaping the price landscape of Dimethylacetamide during the quarter, highlighting the intricate interplay between market forces and sector-specific demands.

Regional Price Analysis:

Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece
North America: United States and Canada
Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru
Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco

Note: The current country list is selective, detailed insights into additional countries can be obtained for clients upon request.

About Us:

IMARC is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145